NT$ 8.65
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very low or no dividends
Data is available to registered users only
Data is available to registered users only
About
Visgeneer, Inc. engages in the provision of biotechnology service. It specializes in blood glucose testers, blood glucose test tablets, blood ketone testers, blood ketone test tablets, and and skin care products. The company was founded on November 15, 2005 and is headquartered in Hsinchu, Taiwan.
Company Valuation
Considering past and projected metrics, the stock is moderately 'expensive' compared to its peers. In particular, the stock is 'expensive' on EV/EBITDA.
Data is available to registered users only